Synedgen, Inc. - Award Notice
Special Notice Posted
- Agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Place of performance
- Claremont, California, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The Special Notice announces the award of Contract Number 75A50124C00047 to Synedgen, Inc. by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response. The $16,937,463.00 contract was awarded under Solicitation Number BAA-23-100-SOL-00004 for the advance development of PAAG17G (DP:MIIST305), a once daily, orally administered, gut-restricted, high molecular weight glycopolymer, as a Medical Countermeasure (MCM) to reduce mortality and morbidity after exposure to lethal ionizing radiation.
The purpose of this contract is to support the further development of PAAG17G as an MCM. The contract performance will take place in the United States, and the closing response date for the original solicitation was October 2, 2024. The contract is not set aside for any specific business category. The NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology), and the PSC code is AN13-P - Health R&D Services; Health Care Services; Experimental Development.
Notice text
Description: Advance development of PAAG17G (DP:MIIST305), a once daily, orally administered, gut-restricted, high molecular weight glycopolymer, as a MCM to reduce mortality and morbidity after exposure to lethal ionizing radiation.
Files
| File | Type | Posted |
|---|---|---|
| SAM Post Award Notification - 9.26.2024 (Synedgen).pdf |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity